Woodline Partners’s BioAtla BCAB Stock Holding History

Woodline Partners’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,526	Closed	-$26.5K	–	928
2025 Q1	$26.5K	Buy	+1,526	New	+$32.6K	﹤0.01%	889
2024 Q2	–	Sell	-2,664	Closed	-$458K	–	564
2024 Q1	$458K	Buy	+2,664	New	+$331K	﹤0.01%	477
2023 Q1	–	Sell	-904	Closed	-$373K	–	637
2022 Q4	$373K	Buy	+904	New	+$375K	0.01%	631
2022 Q1	–	Sell	-8,923	Closed	-$8.76M	–	727
2021 Q4	$8.76M	Buy	8,923 +5,909	+196%	+$7.56M	0.13%	212
2021 Q3	$4.44M	Buy	+3,014	New	+$5.87M	0.07%	272

Other funds holding BCAB

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Woodline Partners's BCAB Position: Q2 2025 in Review

Woodline Partners sold out of BioAtla (BCAB) in Q2 2025, closing a stake of 1,526 shares — an estimated $26.5K sold.

Woodline Partners first reported a position in BCAB in Q3 2021 and held it in 5 quarters. The position peaked at $8.76M in Q4 2021. 39 funds tracked by Wall St. Rank hold BCAB as of Q2 2025.

Woodline Partners reported no remaining BioAtla position as of Q2 2025 after selling out during the quarter.
Woodline Partners sold 1,526 BioAtla shares in Q2 2025, an estimated $26.5K.
Woodline Partners first reported a position in BioAtla in Q3 2021 and held it in 5 quarters.
Woodline Partners's BioAtla position peaked at $8.76M in Q4 2021.
39 funds tracked by Wall St. Rank held BioAtla as of Q2 2025.

Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.